Quick Answer
Matinas BioPharma Holdings, Inc. reported Total Assets of $7.21 million for fiscal year 2025.
Matinas BioPharma Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.21M | -43.0% |
| 2024 | $12.64M | -49.6% |
| 2023 | $25.10M | -44.0% |
| 2022 | $44.82M | -26.9% |
| 2021 | $61.33M | -13.6% |
| 2020 | $70.97M | +76.4% |
| 2019 | $40.24M | +101.8% |
| 2018 | $19.94M | +38.3% |
| 2017 | $14.42M | +46.9% |
| 2016 | $9.82M | +16.8% |
| 2015 | $8.41M | +150.1% |
| 2014 | $3.36M | -70.3% |
| 2013 | $11.33M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.70M | -52.9% | -15.1% |
| June 30, 2025 | $11.42M | -53.1% | -5.1% |
| March 31, 2025 | $12.04M | -38.6% | -4.8% |
| December 31, 2024 | $12.64M | -49.6% | -38.6% |
| September 30, 2024 | $20.58M | -30.9% | -15.5% |
| June 30, 2024 | $24.36M | -28.4% | +24.2% |
| March 31, 2024 | $19.61M | -48.7% | -21.9% |
| December 31, 2023 | $25.10M | -44.0% | -15.7% |
- Matinas BioPharma Holdings, Inc. showed a decrease of -43.0% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Matinas BioPharma Holdings, Inc.’s total assets has declined by 36.4% (from $11.33 million to $7.21 million).
- The most recent figure is from Matinas BioPharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: